VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,475 | -26.3% | 2,094 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $21,000 | -8.7% | 2,094 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $23,000 | -23.3% | 2,094 | -21.2% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -28.6% | 2,659 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $42,000 | -8.7% | 2,659 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $46,000 | -19.3% | 2,659 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $57,000 | +42.5% | 2,659 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $40,000 | +14.3% | 2,659 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $35,000 | +94.4% | 2,659 | +42.8% | 0.01% | +100.0% |
| Q3 2020 | $18,000 | +63.6% | 1,862 | +101.7% | 0.00% | +50.0% |
| Q2 2020 | $11,000 | +10.0% | 923 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $10,000 | – | 923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,581,176 | $60,838,000 | 4.05% |
| ARMISTICE CAPITAL, LLC | 3,548,000 | $47,117,000 | 3.12% |
| Birchview Capital, LP | 80,000 | $1,062,000 | 0.71% |
| 361 CAPITAL LLC | 163,333 | $2,169,000 | 0.40% |
| CADENCE CAPITAL MANAGEMENT LLC | 172,512 | $2,291,000 | 0.32% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 215,936 | $2,868,000 | 0.25% |
| Zebra Capital Management LLC | 15,634 | $208,000 | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 149,139 | $1,981,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 48,207 | $640,000 | 0.14% |
| Virtus ETF Advisers LLC | 47,470 | $630,000 | 0.13% |